This video presents a detailed pathological review of a deeply excised distal forearm nodule from a young female patient, focusing on the differential diagnosis between a cellular soft tissue tumor and other possibilities like sarcoma or melanoma. The lesion exhibits a biphasic pattern: a highly cellular area with large, pleomorphic nuclei, atypical mitoses, and tumor giant cells, juxtaposed with a more myxoid, hypocellular area containing spindly cells in swirling patterns. The speaker strongly guides the analysis toward Cellular Neurothekeoma (or Cellular/Mixed Pattern Neurothekeoma), emphasizing the characteristic bland, histiocytoid nuclei and pale chromatin in the cellular component, which contrast with the worrisome malignant features (pleomorphism, atypical mitoses). It is stressed that despite these features, Cellular Neurothekeoma is a benign entity. A critical diagnostic clue is the presence of areas resembling conventional Nerve Sheath Myxoma (which stains positive for S100/SOX10) or the characteristic features of Cellular Neurothekeoma (which is negative for these markers). The speaker concludes by recommending complete excision, despite literature suggesting observation for atypical cases, citing personal preference for young patients.
Pathology Case Review: Distal Forearm Nodule – Cellular Neurothekeoma
0:00 Case Presentation: Reviewing a case from a 19-year-old female with a distal forearm nodule, excised and sent for consultation.
0:40 Biphasic Lesion Identification: The lesion presents with two distinct areas: a solid, highly cellular nodule and a multi-nodular, loose myxoid area.
1:23 Tip for Trainees: A key teaching point is to always examine the periphery and low-power views first before focusing on the most abnormal, high-power area to avoid missing subtle concurrent pathologies (e.g., melanoma in situ or margin status).
2:35 Cellular Component Features: Characterized by high cellularity, large cells with vesicular/pale open chromatin, and significant mitotic activity, including atypical mitoses, raising initial concern for sarcoma.
3:37 Differential Diagnosis: Sarcoma is considered, but ruled out based on patient age (Mixoid Fibrosarcoma is rare under 50) and specific features. Melanoma is also considered but deemed unlikely based on morphology.
4:55 Histiocyte-like Cells and Tumor Giant Cells: The cellular area features atypical histiocyte-looking cells and numerous multinucleated giant cells that resemble tumor cells rather than background giant cells.
5:35 Myxoid Component: Areas show thin, spindly cells in swirling, chain-like structures within a loose matrix, reminiscent of what was previously called conventional Neurothekeoma (now preferred term: Nerve Sheath Myxoma—a benign, S100/SOX10 positive tumor).
7:51 Diagnosis Confirmation: The mixed pattern (cellular component next to myxoid component) strongly suggests Cellular Neurothekeoma (formerly mixed pattern neurothekeoma).
8:38 Immunohistochemistry Distinction: Cellular Neurothekeoma is negative for neural markers (S100/SOX10), distinguishing it from true nerve sheath tumors like Nerve Sheath Myxoma.
10:09 Cellular Neurothekeoma Characteristics: It is highly cellular, shows nuclear atypia, mitotic activity (even atypical mitoses), and common osteoclast-like giant cells. Importantly, these malignant features do not predict a malignant clinical course.
11:52 Diagnostic Confirmation: Relying on morphology and negative S100/SOX10 staining to exclude melanocytic tumors is the most helpful diagnostic approach.
14:00 The "Kicker": Finding small nests of bland, histiocytoid cells at the periphery—classic for Cellular Neurothekeoma—seals the diagnosis, despite the central tumor looking "wild."
15:06 Management Recommendation: Although literature supports observation for atypical cases, the speaker advises complete excision with ideally negative margins for young patients due to the worrisome morphology, even if the tumor is biologically benign.